Box score
Cardurion Pharmaceuticals, Inc.
Reported $260M sold in a new Form D filed July 24, 2024 (Burlington, Massachusetts).
- Biggest raise
- $260M filed Jul 24, 2024
- League
- Bio & Health Biotechnology
- Based in
- Burlington, Massachusetts
- Season rank
- #10 of 1,389 in the Bio & Health League; #51 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-07-24 | New notice | $260M | $260M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1702453.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Treeline Biosciences, Inc. | Bio & Health | $422M |
| 2 | Seaport Therapeutics, Inc. rookie | Bio & Health | $226M |
| 3 | Zenas BioPharma, Inc. | Bio & Health | $200M |
| 4 | Aktis Oncology, Inc. rookie | Bio & Health | $175M |
| 5 | Organogenesis Holdings Inc. rookie | Bio & Health | $130M |
| 6 | Scorpion Therapeutics, Inc. | Bio & Health | $126M |